These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19776507)

  • 1. Chronic hyperplastic candidosis: a pilot study of the efficacy of 0.18% isotretinoin.
    Scardina GA; Ruggieri A; Messina P
    J Oral Sci; 2009 Sep; 51(3):407-10. PubMed ID: 19776507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candida-related denture stomatitis: a pilot study of the efficacy of an amorolfine antifungal varnish.
    Milillo L; Lo Muzio L; Carlino P; Serpico R; Coccia E; Scully C
    Int J Prosthodont; 2005; 18(1):55-9. PubMed ID: 15754893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic hyperplastic candidosis/candidiasis (candidal leukoplakia).
    Sitheeque MA; Samaranayake LP
    Crit Rev Oral Biol Med; 2003; 14(4):253-67. PubMed ID: 12907694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal topical therapy in oral chronic candidosis. A comparative study.
    Lopez-De-Blanc SA; Salati-De-Mugnolo N; Femopase FL; Benitez MB; Morelatto RA; Astrada-De-Verde L; Masih D
    Med Oral; 2002; 7(4):260-70. PubMed ID: 12134127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluconazole versus nystatin in the treatment of oral candidosis.
    Blomgren J; Berggren U; Jontell M
    Acta Odontol Scand; 1998 Aug; 56(4):202-5. PubMed ID: 9765010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant antifungal therapy using tissue tolerable plasma on oral mucosa and removable dentures in oral candidiasis patients: a randomised double-blinded split-mouth pilot study.
    Preissner S; Kastner I; Schütte E; Hartwig S; Schmidt-Westhausen AM; Paris S; Preissner R; Hertel M
    Mycoses; 2016 Jul; 59(7):467-75. PubMed ID: 26932256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin nanoparticles: the topical antimycotic suspension treating oral candidiasis.
    Anwar SK; Elmonaem SNA; Moussa E; Aboulela AG; Essawy MM
    Odontology; 2023 Apr; 111(2):350-359. PubMed ID: 36100802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adhesion of oral Candida albicans isolates to denture acrylic following limited exposure to antifungal agents.
    Ellepola AN; Samaranayake LP
    Arch Oral Biol; 1998 Dec; 43(12):999-1007. PubMed ID: 9877331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral candidosis. Clinical, historical, and therapeutic features of 100 cases.
    Fotos PG; Vincent SD; Hellstein JW
    Oral Surg Oral Med Oral Pathol; 1992 Jul; 74(1):41-9. PubMed ID: 1508508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).
    Mendling W; Brasch J; Cornely OA; Effendy I; Friese K; Ginter-Hanselmayer G; Hof H; Mayser P; Mylonas I; Ruhnke M; Schaller M; Weissenbacher ER
    Mycoses; 2015 Mar; 58 Suppl 1():1-15. PubMed ID: 25711406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimycotic agents in oral candidosis: an overview: 2. Treatment of oral candidosis.
    Ellepola AN; Samaranayake LP
    Dent Update; 2000 May; 27(4):165-70, 172-4. PubMed ID: 11218451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An ex-vivo oral mucosa infection model for the evaluation of the topical activity of antifungal agents.
    Ohnemus U; Willers C; Bubenheim M; Horstkotte MA; Houdek P; Fischer F; Schmage P; Moll I; Brandner JM
    Mycoses; 2008 Jan; 51(1):21-9. PubMed ID: 18076591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of antifungal drugs on virulence properties of Candida albicans in patients with diabetes mellitus.
    Willis AM; Coulter WA; Fulton CR; Hayes JR; Bell PM; Lamey PJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Mar; 91(3):317-21. PubMed ID: 11250629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of saliva and serum components in patients with oral candidosis topically treated with Ketoconazole and Nystatin.
    Cornejo LS; López de Blanc S; Femopase F; Azcurra A; Calamari S; Battellino LJ; Dorronsoro de Cattoni ST
    Acta Odontol Latinoam; 1998; 11(1):15-25. PubMed ID: 11885450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perianal candidosis--a comparative study with mupirocin and nystatin.
    de Wet PM; Rode H; van Dyk A; Millar AJ
    Int J Dermatol; 1999 Aug; 38(8):618-22. PubMed ID: 10487455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and antifungal susceptibility profiles of Candida glabrata, Candida parapsilosis and their close-related species in oral candidiasis.
    Miranda-Cadena K; Marcos-Arias C; Mateo E; Aguirre JM; Quindós G; Eraso E
    Arch Oral Biol; 2018 Nov; 95():100-107. PubMed ID: 30096698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral candidosis in non-Hodgkin's lymphoma: a case report.
    Siar CH; Ng KH; Rasool S; Ram S; Abdul Jalil A; Ng KP
    J Oral Sci; 2003 Sep; 45(3):161-4. PubMed ID: 14650581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The comparative study of antifungal activity of Syzygium aromaticum, Punica granatum and nystatin on Candida albicans; an in vitro study.
    Mansourian A; Boojarpour N; Ashnagar S; Momen Beitollahi J; Shamshiri AR
    J Mycol Med; 2014 Dec; 24(4):e163-8. PubMed ID: 25442923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral manifestation of chronic mucocutaneous candidiasis: seven case reports.
    Liu X; Hua H
    J Oral Pathol Med; 2007 Oct; 36(9):528-32. PubMed ID: 17850435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.